| Perseus Mining Limited (PRU) ORDINARY FULLY PAID |
Materials |
$7,042 |
Change in substantial holding
|
8 May 2026 8:56AM |
$5.570 |
$5.240 |
fallen by
5.92%
|
|
| SKS Technologies Group Limited (SKS) ORDINARY FULLY PAID |
Industrials |
$917 |
$22M Contract Win for Major Retailers New HQ
|
8 May 2026 8:55AM |
$7.550 |
$7.950 |
risen by
5.30%
|
|
SKS - Price-sensitive ASX Announcement
Full Release
Key Points
- $22 million contract awarded by Buildcorp Group Pty Ltd.
- Project involves an integrated electrical technology solution.
- New headquarters located in Melbourne's Docklands.
- Project completion expected in 1Q28.
- Enhances SKS's market reputation and strategy in non-data centre sectors.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Terragen Holdings Limited (TGH) ORDINARY FULLY PAID |
Materials |
$15 |
Appointment of Non-Executive Director - Paul Whimp
|
8 May 2026 8:54AM |
$0.020 |
$0.018 |
fallen by
10%
|
|
| Accent Group Limited (AX1) ORDINARY FULLY PAID |
Consumer Discretionary |
$331 |
AX1 Investor Strategy Day - Weblink
|
8 May 2026 8:52AM |
$0.555 |
$0.550 |
fallen by
0.90%
|
|
| Alligator Energy Limited (AGE) ORDINARY FULLY PAID |
Energy |
$169 |
Non Executive Director Retirement
|
8 May 2026 8:52AM |
$0.043 |
$0.038 |
fallen by
11.63%
|
|
| Macquarie Group Limited (MQG) ORDINARY FULLY PAID |
Financials |
$91,549 |
Update - Notification of buy-back - MQG
|
8 May 2026 8:51AM |
$241.870 |
$240.200 |
fallen by
0.69%
|
|
| State Gas Limited (GAS) ORDINARY FULLY PAID |
Energy |
$9 |
Application for quotation of securities - GAS
|
8 May 2026 8:49AM |
$0.023 |
$0.022 |
fallen by
4.35%
|
|
| Classic Minerals Limited (CLZ) ORDINARY FULLY PAID |
Materials |
$6 |
Market Update Tenure and Court Proceedings
|
8 May 2026 8:48AM |
$0.001 |
$0.001 |
fallen by
0%
|
|
| ASX Limited (ASX) ORDINARY FULLY PAID |
Financials |
$11,627 |
Appendix 3X - Vic Jokovic
|
8 May 2026 8:45AM |
$60.140 |
$59.500 |
fallen by
1.06%
|
|
| Rivco Australia Ltd (RIV) ORDINARY FULLY PAID |
Utilities |
$228 |
Update - Notification of buy-back - RIV
|
8 May 2026 8:44AM |
$1.420 |
$1.435 |
risen by
1.06%
|
|
| Amaero Ltd (3DA) ORDINARY FULLY PAID |
Industrials |
$334 |
Despatch of Scheme Booklet
|
8 May 2026 8:42AM |
$0.410 |
$0.350 |
fallen by
14.63%
|
|
| Pacific Current Group Limited (PAC) ORDINARY FULLY PAID |
Financials |
$304 |
Update - Notification of buy-back - PAC
|
8 May 2026 8:42AM |
$10.710 |
$10.530 |
fallen by
1.68%
|
|
| Premier Investments Limited (PMV) ORDINARY FULLY PAID |
Consumer Discretionary |
$1,870 |
Update - Notification of buy-back - PMV
|
8 May 2026 8:40AM |
$12.400 |
$11.710 |
fallen by
5.56%
|
|
| Pengana International Equities Limited (PIA) ORDINARY FULLY PAID |
Financials |
$325 |
Capital Management Proposal and Manager Transition
|
8 May 2026 8:40AM |
$1.250 |
$1.260 |
risen by
0.80%
|
|
PIA - Price-sensitive ASX Announcement
Full Release
Key Points
- The board proposed a fully franked special dividend for shareholders, independent of an off-market equal-access Buy-back.
- Shareholders can tender up to 100% of their holdings in the Buy-back at a price based on after-tax NTA per share minus transaction costs.
- A non-renounceable pro-rata rights issue is planned post Buy-back for recapitalisation.
- The proposal includes ongoing discount management mechanisms such as quarterly Buy-backs.
- The transition to Antipodes as the investment manager will commence after capital management processes are completed.
- Important dates include early June 2026 for the Notice of Meeting and approximately 4 weeks later for the Extraordinary General Meeting.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| WOTSO (WOT) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$105 |
Update - Notification of buy-back - WOT
|
8 May 2026 8:40AM |
$0.660 |
$0.650 |
fallen by
1.52%
|
|
| Senetas Corporation Limited (SEN) ORDINARY FULLY PAID |
Information Technology |
$41 |
CEO Investor Presentation - Business Update
|
8 May 2026 8:38AM |
$2.400 |
$2.500 |
risen by
4.17%
|
|
SEN - Price-sensitive ASX Announcement
Full Release
Key Points
- Senetas Corporation Limited provides high-assurance encryption solutions primarily for government and defense sectors.
- The company reported significant business momentum in FY2026, including new contracts and market expansion.
- Completed significant sales through global distribution partner Thales, especially in the Middle East and South America.
- The CN7000 series virtual encryption platform gained traction, marking the largest sale ever of this product into South America.
- Senetas focuses on quantum-resistant encryption, which is crucial for securing future technologies.
- The company holds a solid cash position with a consolidated cash balance of approximately A$20.9 million as of May 2026.
- Senetas has a minority shareholding in Menlo Security, which is a significant growth asset.
- The company's encryption solutions are certified by global security standards including Common Criteria and FIPS.
- Senetas' future strategy involves expanding its encryption technologies into new markets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Argo Investments Limited (ARG) ORDINARY FULLY PAID |
Financials |
$6,625 |
Update - Notification of buy-back - ARG
|
8 May 2026 8:36AM |
$8.840 |
$8.730 |
fallen by
1.24%
|
|
| Arovella Therapeutics Limited (ALA) ORDINARY FULLY PAID |
Health Care |
$85 |
Notification of cessation of securities - ALA
|
8 May 2026 8:33AM |
$0.075 |
$0.070 |
fallen by
6.67%
|
|
| Ariadne Australia Limited (ARA) ORDINARY FULLY PAID |
Industrials |
$93 |
Update - Notification of buy-back - ARA
|
8 May 2026 8:33AM |
$0.480 |
$0.480 |
fallen by
0%
|
|
| ADX Energy Ltd (ADX) ORDINARY FULLY PAID |
Energy |
$24 |
HOCH-1 Well Deepened after Encountering Further Gas
|
8 May 2026 8:33AM |
$0.032 |
$0.027 |
fallen by
15.63%
|
|
ADX - Price-sensitive ASX Announcement
Full Release
Key Points
- HOCH-1 well in Upper Austria encountered additional gas intervals.
- Well deepened to a measured depth of 1619 metres.
- Six additional gas sand intervals found, each 1 to 2 metres thick.
- Wireline logging program scheduled to confirm results.
- HOCH-1 targets Miocene sandstones in the Hall Formation.
- Prospective resource potential estimated between 8.0 and 17.3 BCF.
- ADX Energy Ltd holds a 50% economic interest in the project.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BETR Entertainment Limited (BBT) ORDINARY FULLY PAID |
Consumer Discretionary |
$177 |
Update - Notification of buy-back - BBT
|
8 May 2026 8:31AM |
$0.185 |
$0.170 |
fallen by
8.11%
|
|
| Block, Inc. (XYZ) CDI 1:1 FOREIGN EXEMPT NYSE |
Financials |
$3,572 |
Stockholder Proposal
|
8 May 2026 8:30AM |
$98.340 |
$96.940 |
fallen by
1.42%
|
|
| L1 Long Short Fund Limited (LSF) ORDINARY FULLY PAID |
Financials |
$2,738 |
Net Tangible Asset Backing
|
8 May 2026 8:29AM |
$4.390 |
$4.320 |
fallen by
1.59%
|
|
| Amplia Therapeutics Limited (ATX) ORDINARY FULLY PAID |
Health Care |
$67 |
Amplia and ANZGOG announce Ovarian Cancer Study
|
8 May 2026 8:29AM |
$0.135 |
$0.130 |
fallen by
3.70%
|
|
ATX - Price-sensitive ASX Announcement
Full Release
Key Points
- Amplia Therapeutics Limited and ANZGOG have announced a new clinical study on ovarian cancer.
- The study will evaluate the safety of narmafotinib combined with standard chemotherapy in high-grade serous ovarian cancer patients.
- The trial is named PRROSE and will be conducted in Australia and New Zealand.
- The study focuses on patients who did not respond to standard platinum-based chemotherapy.
- Approximately 15-20 patients are expected to enroll in this trial.
- The study aims to explore if adding narmafotinib can increase surgical success rates.
- Biomarker analysis will be conducted to understand narmafotinib's mechanism of action.
- Dr. Chris Burns from Amplia highlighted the potential of FAK inhibitors in treating ovarian cancer.
- ANZGOG's collaborative network supports the study, which may change clinical practices in gynecological cancers.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Schoolblazer Limited (SBZ) ORDINARY FULLY PAID |
Industrials |
$89 |
Half Year Results and Corporate Update
|
8 May 2026 8:28AM |
$0.200 |
$0.170 |
fallen by
15%
|
|
SBZ - Price-sensitive ASX Announcement
Full Release
Key Points
- Schoolblazer Group achieved $55.4 million in revenue for the first half of the fiscal year.
- The company's revenue is significantly seasonal, with two-thirds generated in the second half.
- Geopolitical issues and increased freight rates impacted sales and margins.
- The group added 28 new contracted schools, bolstering future revenue expectations.
- The company expects FY26 revenue between $190-200 million.
- Schoolblazer Group signed a term sheet with an Australian Bank for refinancing.
- Global CEO Matthew Easter relocated to Australia to lead local growth.
- Schoolblazer Limited realized $2.7 million from its investment portfolio.
- Phillip Christopher was appointed as Group Finance Director.
- The group is progressing towards its FY27 EBITDA target of $25 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.